Inspire Medical Systems, Inc.

Inspire Medical Systems develops and commercializes minimally invasive neurostimulation technology for treating obstructive sleep apnea (OSA). The company's primary product, the Inspire system, delivers mild electrical stimulation to the hypoglossal nerve to maintain airway patency during sleep. The system operates on a closed-loop mechanism that continuously monitors breathing patterns and triggers stimulation as needed, positioning it as an alternative to positive airway pressure (PAP) devices and surgical interventions for patients with moderate to severe OSA.

The company generates revenue primarily through the sale and implantation of Inspire systems, with a business model spanning device sales, procedural services, and patient support. The company operates across the United States and select international markets, though the U.S. represents its principal revenue source.

Inspire Medical Systems employs approximately 1,333 full-time employees and maintains headquarters in Golden Valley, Minnesota. The company is incorporated in Delaware and publicly traded on the New York Stock Exchange.